FAKTOR OPTIONSSCHEIN - STAAR SURGICAL Share Price

Certificat

DE000PL6CSR6

Market Closed - Bid/Ask 19:20:55 01/07/2024 BST
59.47 EUR -3.36% Intraday chart for FAKTOR OPTIONSSCHEIN - STAAR SURGICAL
1 month+85.36%
3 months-61.22%
Date Price Change
01/07/24 59.47 -3.36%
28/06/24 61.54 +15.24%
27/06/24 53.4 +17.60%
26/06/24 45.41 +42.13%
25/06/24 31.95 +22.13%

Real-time Boerse Frankfurt Warrants

Last update July 01, 2024 at 07:20 pm

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying STAAR SURGICAL COMPANY
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PL6CSR
ISINDE000PL6CSR6
Date issued 25/01/2024
Strike 47.61 $
Maturity Unlimited
Parity 1 : 1
Emission price 100
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 791
Lowest since issue 17.08
Spread 3.53
Spread %5.70%

Company Profile

STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. The Company is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. The Company markets and sells ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. The Company’s EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company also markets and sells an ICL lens to treat hyperopia (farsightedness), which is called Visian ICL.
Sector
-
More about the company

Ratings for STAAR Surgical Company

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: STAAR Surgical Company

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
47.61 USD
Average target price
51.68 USD
Spread / Average Target
+8.55%
Consensus